(Q38037141)

27 August 2017

title

5-HT2 ligands in the treatment of anxiety and depression (English)

1 reference

27 August 2017

Gaël Quesseveur

1

1 reference

27 August 2017

Hai T Nguyen

series ordinal

2

1 reference

27 August 2017

Alain M Gardier

series ordinal

3

1 reference

27 August 2017

Bruno P Guiard

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

24 August 2012

1 reference

Expert Opinion on Investigational Drugs

27 August 2017

published in

1 reference

27 August 2017

volume

21

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

1701-1725

1 reference

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The pharmacology of putative early-onset antidepressant strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Is there a role for 5-HT1A agonists in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Neurogenesis and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Therapeutic Potential of 5-HT2CReceptor Ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The 5-HT2C receptor as a target for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Functional study of rat 5‐HT2A receptors using antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

A novel augmentation strategy for treating resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Expression of 5-HT(2A) receptor mRNA in some nuclei of brain stem enhanced in monoarthritic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT(2C) receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Brain structures implicated in the four-plate test in naïve and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Implication of 5-HT(2B) receptors in the serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

D2-like dopamine receptor activation excites rat dorsal raphe 5-HT neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

D2-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT(2B) receptors are required for serotonin-selective antidepressant actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Role of serotonin in central dopamine dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The use of sudden darkness in mice: a behavioural and pharmacological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Anxiolytic effects of 5-HT₁A receptors and anxiogenic effects of 5-HT₂C receptors in the amygdala of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Anxiogenic effects in the rat elevated plus-maze of 5-HT(2C) agonists into ventral but not dorsal hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin 5-HT(2C) receptors regulate anxiety-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The effects of the selective 5-HT(2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Strain-dependent serotonin neuron feedback control: role of serotonin 2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Stimulation of 5-hydroxytryptamine (5-HT(2C) ) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Neurogenesis-dependent and independent effects of anti-depressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

CNTF: a putative link between dopamine D2 receptors and neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-Hydroxytryptamine stimulates the formation of inositol phosphate in astrocytes from different regions of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional 'serotonin-specific reuptake inhibitors'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Glial cells in adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

5-HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Discontinuation symptoms in depression and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Which antidepressants have demonstrated superior efficacy? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Efficacy markers in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Use of bupropion in combination with serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Animal models of neuropsychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Lorcaserin: an investigational serotonin 2C agonist for weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Antidepressants, old and new. A review of their adverse effects and toxicity in overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Perspectives on genetic animal models of serotonin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The serotonin syndrome and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Can olanzapine be implicated in causing serotonin syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

The toxicity of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Genetic variation in the serotonin 2A receptor and suicidal ideation in a sample of 270 Irish high-density schizophrenia families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.719872

10.1517/13543784.2012.719872

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference